Oncogenicity Scoring
Oncogenicity Scoring is a systematic computational or evidence-based framework used in cancer genomics to assess the likelihood that a somatic variant contributes to oncogenesis, distinguished by its integration of functional, evolutionary, and clinical data to prioritize variants according to their putative tumor-driving potential.
71
Publications
4.9K
Citations
415
Authors
169
Institutions
Publications per year
2017–2026
18
71
Peter Horak, Malachi Griffith, Arpad Danos et al. · Genetics in Medicine · 2022 · 239 citations · Full text
1–5 of 71
415
4
h-index
4
h-index
2
h-index
2
h-index
2
h-index
1–5 of 415
169
Dow Chemical (United States)
Midland, United States
11 h-index
43 publications
14K citations
The University of Texas Southwestern Medical Center
Dallas, United States
3 h-index
12 publications
2.5K citations
Memorial Sloan Kettering Cancer Center
New York, United States
3 h-index
21 publications
1.1K citations
Dow Chemical (India)
Mumbai, India
2 h-index
2 publications
99 citations

Brigham and Women's Hospital
Boston, United States
2 h-index
6 publications
379 citations
National Cancer Institute
Bethesda, United States
2 h-index
5 publications
793 citations

Children's Hospital of Philadelphia
Philadelphia, United States
2 h-index
7 publications
611 citations
Harvard University
Cambridge, United States
2 h-index
3 publications
293 citations
1–8 of 169
12 publications · 479 citations
12
h-index
Repository · 4 publications · 147 citations
4
h-index
TAAP · 3 publications · 1.5K citations
3
h-index
2 publications · 57 citations
2
h-index
RTP · 2 publications · 26 citations
2
h-index
1–5